CytoView? is an integrated all-in-one imaging system with artificial intelligence (AI) solution for the identification of circulating tumor cells and circulating fetal cells. Cell-based liquid biopsy is a multi-step, diagnostic process requiring blood sample preparation, cell enrichment, immunostaining, and molecular analysis such as fluorescence in situ hybridization (FISH) and next-generation sequencing (NGS). The immunostaining and FISH analysis is a critical component of the cell distinction requiring high-speed cell scanning with smart artificial intelligence (AI) coupled with direct sample viewing to accelerate and shorten the cycle time from blood sample to report.
Most scanning microscopes in the market do not have AI capability to analyze the captured images. Moreover, the scanning microscope does not always have sufficient viewing resolution for final confirmation. CytoView? distinguishes each cell’s protein and genomic signature, and more importantly their intercellular heterogeneity and homogeneity. This foremost identification is first validation step followed by more intensive DNA and RNA validation at greater breadth and depth. CytoView? is a highly competitive, imaging and smart-algorithm platform customized for the non-invasive, cell-based liquid biopsy market.